False
November 25, 2025
From the University of Houston to MD Anderson Cancer Center, Cole Woody’s journey shows how curiosity and collaboration can drive major discoveries. He reflects on the promise of repurposed mRNA vaccines, the technical art of immunology, and the social side of science.
7 min read
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.
The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.
We interview Scott Billman, one of the judges of the ISPE Facility of the Year Awards, to learn more about the 2025 winners and the trends impacting facilities.
All the latest Medicine Maker articles.
November 18, 2025
Our latest news roundup reports on the FDA’s new “plausible mechanism” pathway, Novartis’s phase III malaria trial, a new gene therapy in Europe, and more.
4 min read
November 17, 2025
Digital tools, live imaging, and molecular engineering are pushing the boundaries of what’s possible in preclinical development
8 min read
November 14, 2025
Southwest Research Institute chemists share how a chance mishap with deionized water led to a method that may accelerate the purification of active drug ingredients
7 min read
November 13, 2025
Phase I trial finds intranasal, adjuvanted recombinant H5 influenza vaccine primes strong mucosal and systemic immunity – subsequent injection boost yields cross-clade protection against multiple H5N1 viruses.
1 min read
November 13, 2025
In stroke patients with dysphagia, the default practice of crushing tablets could increase residue, reduce efficacy, and raise aspiration risk. Researchers reveal how individualized FEES assessments can transform medication safety at the bedside.
5 min read
November 13, 2025
We get the lowdown on Kindeva’s new, multi-use facility in Bridgeton and trends in the market.
November 12, 2025
Engineered tRNAs are redefining precision RNA therapeutics, restoring protein function in diseases caused by nonsense mutations, and bridging the gap between RNA and gene editing technologies.
5 min read
November 12, 2025
Our latest news roundup reports on Novartis’ new radioligand facility in California, new tech for boosting AAV yields, and MeiraGTx’s deal with Eli Lilly
4 min read
November 11, 2025
Interim results from a clinical trial addressing a fatal brain matter disorder suggest that gene therapy could be an effective approach
3 min read
November 11, 2025
Lyell Immunopharma acquires rights to CAR T cell therapy for solid tumors
2 min read
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.
False
